173 related articles for article (PubMed ID: 9111121)
1. "Litigation cells" in the Papanicolaou smear: extramural review of smears by "experts".
Frable WJ
Arch Pathol Lab Med; 1997 Mar; 121(3):292-5. PubMed ID: 9111121
[TBL] [Abstract][Full Text] [Related]
2. Quality and liability issues with the Papanicolaou smear: the problem of definition of errors and false-negative smears.
Davey DD
Arch Pathol Lab Med; 1997 Mar; 121(3):267-9. PubMed ID: 9111115
[TBL] [Abstract][Full Text] [Related]
3. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process.
Renshaw AA; DiNisco SA; Minter LJ; Cibas ES
Cancer; 1997 Oct; 81(5):272-6. PubMed ID: 9349513
[TBL] [Abstract][Full Text] [Related]
4. Blinded review of papanicolaou smears.
Frable WJ
Cancer; 2004 Jun; 102(3):133-5. PubMed ID: 15211470
[No Abstract] [Full Text] [Related]
5. Common problems in Papanicolaou smear interpretation.
DeMay RM
Arch Pathol Lab Med; 1997 Mar; 121(3):229-38. PubMed ID: 9111106
[TBL] [Abstract][Full Text] [Related]
6. Does a zero error standard exist for the Papanicolaou smear? A pathologist's perspective.
Frable WJ
Arch Pathol Lab Med; 1997 Mar; 121(3):301-10. PubMed ID: 9111124
[TBL] [Abstract][Full Text] [Related]
7. Medicolegal affairs. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
Frable WJ; Austin RM; Greening SE; Collins RJ; Hillman RL; Kobler TP; Koss LG; Mitchell H; Perey R; Rosenthal DL; Sidoti MS; Somrak TM
Acta Cytol; 1998; 42(1):76-119; discussion 120-32. PubMed ID: 9479326
[TBL] [Abstract][Full Text] [Related]
8. Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: a study of 49 cases.
Krane JF; Granter SR; Trask CE; Hogan CL; Lee KR
Cancer; 2001 Feb; 93(1):8-15. PubMed ID: 11241260
[TBL] [Abstract][Full Text] [Related]
9. Blinded review of Papanicolaou smears.
Gill GW
Cancer; 2005 Apr; 105(2):53-5. PubMed ID: 15662699
[No Abstract] [Full Text] [Related]
10. Pitfalls in diagnostic cervicovaginal cytology.
Sidawy MK; Solomon D
Monogr Pathol; 1997; (39):1-15. PubMed ID: 9249817
[No Abstract] [Full Text] [Related]
11. Blinded review of Papanicolaou smears in the context of litigation.
Renshaw AA; Young ML; Holladay EB
Cancer; 2004 Jun; 102(3):136-41. PubMed ID: 15211471
[TBL] [Abstract][Full Text] [Related]
12. Liability issues with the Papanicolaou smear: a defense lawyer's perspective.
Varner CD
Arch Pathol Lab Med; 1997 Mar; 121(3):315-20. PubMed ID: 9111126
[No Abstract] [Full Text] [Related]
13. The false-negative fraction for Papanicolaou smears: how often are "abnormal" smears not detected by a "standard" screening cytologist?
Naryshkin S
Arch Pathol Lab Med; 1997 Mar; 121(3):270-2. PubMed ID: 9111116
[TBL] [Abstract][Full Text] [Related]
14. Significance of MiB-1 staining in smears with atypical glandular cells.
Boon ME; Vinkestein A; van Binsbergen-Ingelse A; van Haaften C
Diagn Cytopathol; 2004 Aug; 31(2):77-82. PubMed ID: 15282717
[TBL] [Abstract][Full Text] [Related]
15. Papanicolaou smear: can we make a good test better? Technical and interpretive challenges for the practitioner.
Eltabbakh GH; Eltabbakh GD
J Womens Health Gend Based Med; 1999 May; 8(4):469-76. PubMed ID: 10839701
[TBL] [Abstract][Full Text] [Related]
16. [Cervical smears unsuitable for exclusion of cervical carcinoma].
Giard RW; Blok P
Ned Tijdschr Geneeskd; 2000 Jan; 144(2):86-7. PubMed ID: 10674109
[TBL] [Abstract][Full Text] [Related]
17. Glandular cell atypia on Papanicolaou smears: interobserver variability in the diagnosis and prediction of cell of origin.
Simsir A; Hwang S; Cangiarella J; Elgert P; Levine P; Sheffield MV; Roberson J; Talley L; Chhieng DC
Cancer; 2003 Dec; 99(6):323-30. PubMed ID: 14681938
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance.
Duncan L; Jacob S; Hubbard E
Cancer; 2008 Feb; 114(1):34-48. PubMed ID: 18186493
[TBL] [Abstract][Full Text] [Related]
19. [Applicative aspects of liquid-based cytology in cervical cancer screening].
Liverani M; De Paola F; Danesi S; Fedriga R; Dalbuoni V; Agnoletti R; Amadori AR; Mirra F; Bonoli W; Saragoni L
Pathologica; 2006 Dec; 98(6):629-34. PubMed ID: 17285839
[TBL] [Abstract][Full Text] [Related]
20. The significance of atypical glandular cells on routine cervical cytologic testing in a community-based population.
Chin AB; Bristow RE; Korst LM; Walts A; Lagasse LD
Am J Obstet Gynecol; 2000 Jun; 182(6):1278-82. PubMed ID: 10871439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
